Physician
Dermatology
Dr. Stephen K. Richardson, MD
|
|
Give Review
Stephen Richardson works in the field of Dermatology. He graduated from Harvard Medical School. Harvard Medical School is a top medical college. Harvard Medical School is ranked 1/12 in Research/PrimaryCare. He received 2 awards: "CMS Meaningful Use Stage 1 Certification" and "Fellow (FAAD)". Stephen Richardson is a published MD as well. He has 18 publications published. The latest was: Update on the epidemiology and systemic treatment of psoriasis. Stephen Richardson is registered with Medicare.
Publications
- In vivo imaging of cutaneous T-Cell lymphoma migration to the skin.
- Serial isolates of persistent Haemophilus influenzae in patients with chronic obstructive pulmonary disease express diminishing quantities of the HMW1 and HMW2 adhesins.
- Clinical and in vitro resistance to bexarotene in adult T-Cell leukemia: loss of RXR-alpha receptor.
- Total Skin electron beam therapy may be associated with improvement of peripheral blood disease in Sézary syndrome.
- IL-21 enhances antitumor responses without stimulating proliferation of malignant T Cells of patients with Sézary syndrome.
- Update on the natural history and systemic treatment of Psoriasis.
- Progressive multifocal leukoencephalopathy from JC virus in a patient with advanced mycosis fungoides.
- Bexarotene blunts malignant T-Cell chemotaxis in Sezary syndrome: reduction of chemokine receptor 4-positive lymphocytes and decreased chemotaxis to thymus and activat...
- Synthetic imidazoquinolines potently and broadly activate the Cellular immune response of patients with cutaneous T-Cell lymphoma: synergy with interferon-gamma enhanc...
- High clinical response rate with multimodality immunomodulatory therapy for Sézary syndrome.
- Immunopathogenesis and therapy of cutaneous T Cell lymphoma.
- Biological effects of bexarotene in cutaneous T-Cell lymphoma.
- Extracorporeal photopheresis and multimodality immunomodulatory therapy in the treatment of cutaneous T-Cell lymphoma.
- Congenital and infantile melanoma: review of the literature and report of an uncommon variant, pigment-synthesizing melanoma.
- Cytokines and other biologic agents as immunotherapeutics for cutaneous T-Cell lymphoma.
- Update on the epidemiology and systemic treatment of Psoriasis.
- The use of cytokines, fusion proteins and antibodies to treat cutaneous T-Cell lymphoma.
Schools
HARVARD MED SCH
Procedures Preformed
- Destruction of Benign Skin Lesion
- Destruction of Malignant Skin Lesion
- Excision of Benign Skin Lesion
- Excision of Malignant Skin Lesion
- View All
Conditions Treated
- Acne
- Actinic Keratosis
- Athlete's Foot
- Basal Cell Carcinoma
- View All
Doctors Specialties
- Dermatology
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
- Fellow (FAAD)
Education
-
University of Pennsylvania Health System -
Harvard Medical School
Drug Facts
| NPI NUMBER | 1710918404 | |
| NPPES Provider LastName | RICHARDSON | |
| NPPES Provider FirstName | STEPHEN | |
| NPPES Provider ZIPCode | 323085317 | |
| NPPES Provider State | FL | |
| Specialty Description | Dermatology | |
| Total Claim Count | 959.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1710918404 |
| Last Name Of The Provider | RICHARDSON |
| First Name Of The Provider | STEPHEN |
| View All |
Similar Doctors
|
Dr. Douglas P. Sherman, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michael J. Ford, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Pamela S. Kennedy, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Ravi R. Ubriani, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. David E. Hood, MD |
|
|
Dr. Bhavik P. Soni, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Oen-Hiang C. Tie, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Okanta B. Jackson, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Cynthia Tie, MD |
|
|
Dr. William H. Green, MD |